Fiscal year 2026 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses PBH in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named PBH in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Ronald Lombardi | $1,003,564 | $0 | $4,099,959 | $0 | $850,000 | $0 | $51,024 | $6,004,547 |
| Chair of the Board, President and Chief Executive Officer | ||||||||
| Christine Sacco | 716,242 | 0 | 1,608,733 | 0 | 364,650 | 0 | 24,203 | 2,713,828 |
| Chief Financial Officer and Chief Operating Officer | ||||||||
| William P'Pool | 565,565 | 0 | 562,024 | 0 | 191,080 | 0 | 13,923 | 1,332,592 |
| Senior Vice President, General Counsel and Corporate Secretary | ||||||||
| Adel Mekhail | 548,549 | 0 | 543,934 | 0 | 221,952 | 0 | 15,908 | 1,330,343 |
| Executive Vice President, Sales and Marketing | ||||||||
| Jeffrey Zerillo | 384,227 | 0 | 381,044 | 0 | 111,404 | 0 | 15,908 | 892,583 |
| Senior Vice President, Operations | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2026 total | FY2025 total | FY2024 total | Δ FY2025→2026 |
|---|---|---|---|---|
| Ronald Lombardi | $6,004,547 | — | — | — |
| Christine Sacco | 2,713,828 | 3,905,601 | 2,000,849 | −1,191,773 |
| William P'Pool | 1,332,592 | 1,406,460 | — | −73,868 |
| Adel Mekhail | 1,330,343 | — | — | — |
| Jeffrey Zerillo | 892,583 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Ronald Lombardi | PSU | 37,057 | — | $2,196,368 |
| Christine Sacco | PSU | 11,632 | — | 689,429 |
| Ronald Lombardi | RSU | 9,532 | — | 564,962 |
| Adel Mekhail | PSU | 4,530 | — | 268,493 |
| Adel Mekhail | PSU | 4,684 | — | 277,621 |
| Christine Sacco | RSU | 4,042 | — | 239,569 |
| Jeffrey Zerillo | PSU | 2,755 | — | 163,289 |
| Adel Mekhail | RSU | 2,622 | — | 155,406 |
| Adel Mekhail | RSU | 2,014 | — | 119,370 |
| Jeffrey Zerillo | RSU | 1,837 | — | 108,879 |
| Ronald Lombardi | RSU | 4,995 | — | 296,054 |
| Christine Sacco | RSU | 7,755 | — | 459,639 |
| Adel Mekhail | PSU | 4,064 | — | 240,873 |
| Ronald Lombardi | RSU | 12,352 | — | 732,103 |
| Christine Sacco | PSU | 9,094 | — | 539,001 |
| Adel Mekhail | PSU | 3,933 | — | 233,109 |
| Jeffrey Zerillo | PSU | 3,174 | — | 188,123 |
| Jeffrey Zerillo | RSU | 1,411 | — | 83,630 |
| Adel Mekhail | RSU | 3,505 | — | 207,741 |
| Adel Mekhail | RSU | 2,709 | — | 160,562 |
| Ronald Lombardi | RSU | 31,468 | — | 1,865,108 |
| Adel Mekhail | RSU | 1,113 | — | 65,968 |
| Adel Mekhail | RSU | 3,675 | — | 217,817 |
| Adel Mekhail | RSU | 2,082 | — | 123,400 |
| Adel Mekhail | RSU | 1,167 | — | 69,168 |
| Christine Sacco | RSU | 21,136 | — | 1,252,731 |
| Christine Sacco | RSU | 2,225 | — | 131,876 |
| Christine Sacco | RSU | 7,008 | — | 415,364 |
| Ronald Lombardi | PSU | 42,894 | — | 2,542,327 |
| Jeffrey Zerillo | RSU | 778 | — | 46,112 |
| Jeffrey Zerillo | RSU | 2,450 | — | 145,212 |
It is the intent of the Company, through the efforts of the Compensation and Talent Management Committee, to: Motivate our business leaders to deliver a high degree of business performance and ensure that their interests are closely aligned with those of our stockholders; Attract and retain highly qualified senior leaders who can drive a successful global enterprise in today's competitive marketplace and represent the diversity of our employees and the customers we serve; Establish executive compensation that is competitive with the compensation offered by similarly situated companies; Focus management on both the Company's short-term and long-term strategy, performance and success; Maintain practices that support good governance; and Structure programs that mitigate any incentives to take excessive risks.
| CEO STI target (% of salary) | 125% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Compensation Advisory Partners (CAP) |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2025 | 2025-08-05 | 46,414,288 | 559,017 | 131,377 | 98.81% | Passed |
| 2024 | 2024-08-06 | 45,329,756 | 878,293 | 16,994 | 98.1% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2025 | 2025-08-05 | 98.81%a |
| 2024 | 2024-08-06 | 98.1%b |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| John E. ByomIndependent · Lead Independent Director · Audit and Finance · Compensation and Talent Management | $165,502 | $155,040 | $0 | — | $0 | $320,542 |
| Dawn M. ZierIndependent · Audit and Finance · Compensation and Talent Management (Chair) | 115,000 | 155,040 | 0 | — | 0 | 270,040 |
| James C. D'AreccaIndependent · Audit and Finance (Chair) · Nominating and Corporate Governance | 115,000 | 155,040 | 0 | — | 0 | 270,040 |
| Celeste A. ClarkIndependent · Compensation and Talent Management · Nominating and Corporate Governance (Chair) | 110,000 | 155,040 | 0 | — | 0 | 265,040 |
| Katherine A. HopkinsIndependent · Not standing for re-election | 95,000 | 155,040 | 0 | — | 0 | 250,040 |
| John F. KellyIndependent · Compensation and Talent Management · Nominating and Corporate Governance | 95,000 | 155,040 | 0 | — | 0 | 250,040 |
| Ronald M. LombardiEmployee director · Board Chair | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | — |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 20,000 / 15,000 |
| Stock ownership guideline | — |
| Component | FY2026 |
|---|---|
| Cash retainers and fees | $695,502 |
| Equity awards (grant-date value) | $930,240 |
| All other compensation | $0 |
| Total cost of the board | $1,625,742 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Prestige Consumer Healthcare names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Prestige Consumer Healthcare.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Corcept Therapeutics Incorporated | 2025 | Joseph Belanoff | $1,182,333 | $0 | $12,907,718 | $0 | $15,303,551 |
| 2 | Pacira BioSciences, Inc. | 2025 | Frank Lee | 935,308 | 9,215,500 | 0 | 738,810 | 11,636,917 |
| 3 | Energizer Holdings, Inc. | 2025 | Mark LaVigne | 1,045,500 | 8,605,084 | 0 | 1,145,665 | 10,972,516 |
| 4 | Church & Dwight Co. | 2025 | Richard Dierker | 986,580 | 1,770,973 | 5,313,100 | 1,472,656 | 9,799,678 |
| 5 | Edgewell Personal Care Company | 2025 | Rod Little | 1,100,000 | 7,576,100 | 0 | 907,500 | 9,754,366 |
| 6 | Spectrum Brands Holdings Inc. | 2025 | David Maura | 900,000 | 6,750,004 | 0 | 907,200 | 8,757,036 |
| 7 | Amphastar Pharmaceuticals | 2025 | Jack Yongfeng Zhang | 950,911 | 3,301,981 | 3,302,024 | 361,000 | 8,309,350 |
| 8 | Prestige Consumer Healthcare | 2026 | Ronald Lombardi | 1,003,564 | 4,099,959 | 0 | 850,000 | 6,004,547 |
| 9 | Hain Celestial Group, Inc. | 2025 | Wendy Davidson | 789,808 | 3,530,682 | 0 | 0 | 4,546,417 |
| 10 | Helen of Troy Limited | 2026 | Noel Geoffroy | 177,000 | 3,800,000 | 0 | 39,982 | 4,070,466 |
| — | Simply Good Foods Company | — | — | — | — | — | — | not in coverage universe |
| — | BellRing Brands, Inc. | — | — | — | — | — | — | not in coverage universe |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Prestige Consumer Healthcare | 68% | PSU 75 · RSU 25 | No | Compensation Advisory Partners (CAP) |
| Amphastar Pharmaceuticals | not disclosed | Options 50 · RSU 50 | not disclosed | Willis Towers Watson (WTW) |
| BellRing Brands, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| Church & Dwight Co. | 125% | Options 75 · PSU 15 · RSU 10 | No | Semler Brossy Consulting Group |
| Corcept Therapeutics Incorporated | 100% | not disclosed | not disclosed | not disclosed |
| Edgewell Personal Care Company | 66% | not disclosed | No | Meridian |
| Energizer Holdings, Inc. | 87.67% | PSU 70 · RSU 30 | No | Farient |
| Hain Celestial Group, Inc. | not disclosed | RSU 50 · PSU 50 | Yes — Relative TSR versus the S&P Food & Beverage Select Industry Index | ClearBridge Compensation Group, LLC |
| Helen of Troy Limited | 16.3% | PSU 50 · RSU 50 | No | FW Cook |
| Pacira BioSciences, Inc. | 90% | RSU 100 | No | Aon (Aon plc, Human Capital Solutions practice) |
| Simply Good Foods Company | not disclosed | not disclosed | not disclosed | not disclosed |
| Spectrum Brands Holdings Inc. | not disclosed | PSU 70 · RSU 30 | No | WTW (Willis Towers Watson) |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Ronald Lombardi | DEF 14A | 2026-06-29 | 0001295947-26-000021 | Section “Summary Compensation Table”. As printed: 6,004,547. Filing ↗machine: span 1927946–1927955 |
| 2 | Section 01, Christine Sacco | DEF 14A | 2026-06-29 | 0001295947-26-000021 | Section “Summary Compensation Table”. As printed: 2,713,828. Filing ↗machine: span 1942395–1942404 |
| 3 | Section 01, William P'Pool | DEF 14A | 2026-06-29 | 0001295947-26-000021 | Section “Summary Compensation Table”. As printed: 1,332,592. Filing ↗machine: span 1972343–1972352 |
| 4 | Section 01, Adel Mekhail | DEF 14A | 2026-06-29 | 0001295947-26-000021 | Section “Summary Compensation Table”. As printed: 1,330,343. Filing ↗machine: span 1957522–1957531 |
| 5 | Section 01, Jeffrey Zerillo | DEF 14A | 2026-06-29 | 0001295947-26-000021 | Section “Summary Compensation Table”. As printed: 892,583. Filing ↗machine: span 1987115–1987122 |
| 6 | Section 08, John E. Byom | DEF 14A | 2026-06-29 | 0001295947-26-000021 | Section “Director Compensation”. As printed: 320,542. Filing ↗machine: t125 · r2 · c3 · span 1270144–1270151 |
| 7 | Section 08, Dawn M. Zier | DEF 14A | 2026-06-29 | 0001295947-26-000021 | Section “Director Compensation”. As printed: 270,040. Filing ↗machine: t125 · r7 · c3 · span 1282937–1282944 |
| 8 | Section 08, James C. D'Arecca | DEF 14A | 2026-06-29 | 0001295947-26-000021 | Section “Director Compensation”. As printed: 270,040. Filing ↗machine: t125 · r4 · c3 · span 1275195–1275202 |
| 9 | Section 08, Celeste A. Clark | DEF 14A | 2026-06-29 | 0001295947-26-000021 | Section “Director Compensation”. As printed: 265,040. Filing ↗machine: t125 · r3 · c3 · span 1272713–1272720 |
| 10 | Section 08, Katherine A. Hopkins | DEF 14A | 2026-06-29 | 0001295947-26-000021 | Section “Director Compensation”. As printed: 250,040. Filing ↗machine: t125 · r5 · c3 · span 1277757–1277764 |
| 11 | Section 08, John F. Kelly | DEF 14A | 2026-06-29 | 0001295947-26-000021 | Section “Director Compensation”. As printed: 250,040. Filing ↗machine: t125 · r6 · c3 · span 1280229–1280236 |
| 12 | Section 08, Ronald M. Lombardi | DEF 14A | 2026-06-29 | 0001295947-26-000021 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 13 | Section 06, 2025 vote | Form 8-K | 2025-08-07 | 0001295947-25-000029 | Item 5.07 · say-on-pay result. As reported: 98.81%. Filing ↗ |
| 14 | Section 06, 2024 vote | Form 8-K | 2024-08-08 | 0001295947-24-000025 | Item 5.07 · say-on-pay result. As reported: 98.1%. Filing ↗ |
| 15 | Section 01 trend, Δ column (computed) | Computed | — | computed | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 16 | Section 09b board cost (computed) | Computed | — | computed | Cash 695,502 + equity 930,240 + all other 0 = 1,625,742, summed across the director compensation table rows.machine: formula: Σ = 1,625,742 |
| 17 | Corcept Therapeutics Incorporated, Section 10b CEO total | DEF 14A | 2026-04-17 | 0001628280-26-025735 | CEO total compensation as printed in Corcept Therapeutics Incorporated's own proxy. As printed: 15,303,551. Filing ↗machine: span 283504–283514 |
| 18 | Pacira BioSciences, Inc., Section 10b CEO total | DEF 14A | 2026-04-28 | 0001104659-26-050353 | CEO total compensation as printed in Pacira BioSciences, Inc.'s own proxy. As printed: 11,636,917. Filing ↗machine: t136 · r1 · c47 · span 2412158–2412168 |
| 19 | Energizer Holdings, Inc., Section 10b CEO total | DEF 14A | 2025-12-12 | 0001632790-25-000120 | CEO total compensation as printed in Energizer Holdings, Inc.'s own proxy. As printed: 10,972,516. Filing ↗machine: span 836550–836560 |
| 20 | Church & Dwight Co., Section 10b CEO total | DEF 14A | 2026-03-19 | 0001193125-26-115994 | CEO total compensation as printed in Church & Dwight Co.'s own proxy. As printed: 9,799,678. Filing ↗machine: r2 · c38 · span 2534673–2534682 |
| 21 | Edgewell Personal Care Company, Section 10b CEO total | DEF 14A | 2025-12-22 | 0001104659-25-123567 | CEO total compensation as printed in Edgewell Personal Care Company's own proxy. As printed: 9,754,366. Filing ↗machine: t89 · r1 · c51 · span 1153139–1153148 |
| 22 | Spectrum Brands Holdings Inc., Section 10b CEO total | DEF 14A | 2026-06-26 | 0000109177-26-000030 | CEO total compensation as printed in Spectrum Brands Holdings Inc.'s own proxy. As printed: 8,757,036. Filing ↗machine: r3 · c45 · span 689937–689946 |
| 23 | Amphastar Pharmaceuticals, Section 10b CEO total | DEF 14A | 2026-04-13 | 0001297184-26-000023 | CEO total compensation as printed in Amphastar Pharmaceuticals's own proxy. As printed: 8,309,350. Filing ↗machine: span 722923–722932 |
| 24 | Prestige Consumer Healthcare (subject), Section 10b CEO total | DEF 14A | 2026-06-29 | 0001295947-26-000021 | CEO total compensation as printed in Prestige Consumer Healthcare's own proxy. As printed: 6,004,547. Filing ↗machine: span 1927946–1927955 |
| 25 | Hain Celestial Group, Inc., Section 10b CEO total | DEF 14A | 2025-09-18 | 0001193125-25-207370 | CEO total compensation as printed in Hain Celestial Group, Inc.'s own proxy. As printed: 4,546,417. Filing ↗machine: t83 · r14 · c38 · span 1813238–1813247 |
| 26 | Helen of Troy Limited, Section 10b CEO total | DEF 14A | 2026-06-24 | 0000916789-26-000088 | CEO total compensation as printed in Helen of Troy Limited's own proxy. As printed: 4,070,466. Filing ↗machine: span 888837–888846 |
| 27 | Section 10a, Edgewell Personal Care Company reciprocity | DEF 14A | — | 0001104659-25-123567 | Edgewell Personal Care Company names Prestige Consumer Healthcare in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 28 | Section 10a, Amphastar Pharmaceuticals reciprocity | DEF 14A | — | 0001297184-26-000023 | Amphastar Pharmaceuticals names Prestige Consumer Healthcare in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 29 | Section 10a, Energizer Holdings, Inc. reciprocity | DEF 14A | — | 0001632790-25-000120 | Energizer Holdings, Inc. names Prestige Consumer Healthcare in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 30 | Section 10a, Spectrum Brands Holdings Inc. reciprocity | DEF 14A | — | 0000109177-26-000030 | Spectrum Brands Holdings Inc.'s most recent proxy was read; its disclosed peer group does not include Prestige Consumer Healthcare. Filing ↗ |
| 31 | Section 10a, Helen of Troy Limited reciprocity | DEF 14A | — | 0000916789-26-000088 | Helen of Troy Limited names Prestige Consumer Healthcare in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 32 | Section 10a, Pacira BioSciences, Inc. reciprocity | DEF 14A | — | 0001104659-26-050353 | Pacira BioSciences, Inc.'s most recent proxy was read; its disclosed peer group does not include Prestige Consumer Healthcare. Filing ↗ |
| 33 | Section 10a, Hain Celestial Group, Inc. reciprocity | DEF 14A | — | 0001193125-25-207370 | Hain Celestial Group, Inc.'s most recent proxy was read; its disclosed peer group does not include Prestige Consumer Healthcare. Filing ↗ |